Alzheimer's disease diagnosis based on mitogen-activated protein kinase phosphorylation
US9188595B2 · kind B2 · utility
4Cited by
6References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 22, 2010 |
| Grant date | Nov 17, 2015 |
| Priority date | — |
| Expiry date | Mar 22, 2030 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/2821
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of diagnosing Alzheimer's disease in a patient comprises determining whether the phosphorylation level of an indicator protein in cells of the patient after stimulus with an activator compound is abnormally elevated as compared to a basal phosphorylation level, the indicator protein being e.g. Erk1/2 and the activator compound being e.g. bradykinin.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.